Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
纳武利尤单抗治疗错配修复缺陷或高突变妇科癌症:一项包含生物标志物分析的 2 期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-024-02942-7
Friedman, Claire F; Manning-Geist, Beryl L; Zhou, Qin; Soumerai, Tara; Holland, Aliya; Da Cruz Paula, Arnaud; Green, Hunter; Ozsoy, Melih Arda; Iasonos, Alexia; Hollmann, Travis; Leitao, Mario M Jr; Mueller, Jennifer J; Makker, Vicky; Tew, William P; O'Cearbhaill, Roisin E; Liu, Ying L; Rubinstein, Maria M; Troso-Sandoval, Tiffany; Lichtman, Stuart M; Schram, Alison; Kyi, Chrisann; Grisham, Rachel N; Causa Andrieu, Pamela; Wherry, E John; Aghajanian, Carol; Weigelt, Britta; Hensley, Martee L; Zamarin, Dmitriy